ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 인후암 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 치료 접근법의 혁신, 신기술을 이용한 진단 도구의 강화, 신약과 치료법의 출현, 예측 진단을 위한 AI와 머신러닝의 이용, 음성 치료 솔루션의 디지털 통합 등이 있습니다.
흡연 인구 증가는 향후 몇 년간의 인후암 시장의 성장을 가속할 것으로 예측됩니다. 이 흡연 인구는 스트레스 수준의 상승에 의해 증가하고 있으며, 대처 전략으로서 흡연에 의지하는 사람이 늘어나고 있습니다. 흡연의 발생을 줄이기 위한 공중의식과 예방 노력의 긴급의 필요성을 강조하고 있습니다. 2024년 10월, European Respiratory Society는 젊은층의 흡연율이 2022년 22.5%에서 2024년 40.1%로 대폭 상승했다고 보고했습니다. 그 결과, 흡연 인구 증가가 인후암 시장의 확대에 기여하고 있습니다.
인후암 시장의 주요 기업은 치료 효과와 환자의 생존율을 향상시키기 위해 면역종양약 등의 혁신적인 치료법의 개발에 힘을 쏟고 있습니다. 2024년 11월, Dr.Reddy's Laboratories Ltd.는 인후암의 희귀하고 침공성이 높은 유형인 상인후암의 치료제로서 Toripalimab을 발매했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인후암 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 인후암 시장 : 성장률 분석
세계의 인후암 시장 실적 : 규모와 성장, 2019-2024년
세계의 인후암 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 인후암 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 인후암 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029년, 2034년
인후암
후두암
세계의 인후암 시장 : 치료법별 분석과 예측, 2019-2024년, 2024-2029년, 2034년
수술
방사선치료
표적요법
화학요법
대사 길항제
백금 유도체
식물 유래 성분
질소 겨자류
항생제
기타
세계의 인후암 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
암 연구 기관
다과 클리닉
외래수술센터(ASC)
세계의 인후암 시장 : 인후암 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
중인후암
비인후암
하인후암
세계의 인후암 시장 : 후두암 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
성문암
성문상암
성문하암
제7장 지역별/국가별 분석
세계의 인후암 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 인후암 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
인후암 시장 : 경쟁 구도
인후암 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck and Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bristol Myers Squibb
AstraZeneca plc
Novartis AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Amgen Inc.
Astellas Pharma Inc.
Dr. Reddy's Laboratories
Biocon Ltd.
Coherus BioSciences Inc.
Inovio Pharmaceuticals Inc.
Boston Biomedical Inc.
Shanghai Sunway Biotech Co. Ltd.
Odon Life Sciences
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
인후암 시장(2029년) : 새로운 기회를 제공하는 국가
인후암 시장(2029년) : 새로운 기회를 제공하는 부문
인후암 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Throat cancer is characterized by the development of malignant cells within the throat tissues, encompassing areas such as the pharynx, larynx, and tonsils. Common symptoms include a persistent sore throat, hoarseness, and difficulty swallowing. The condition is frequently associated with risk factors like tobacco use, alcohol consumption, and infection with the human papillomavirus (HPV).
There are two primary forms of throat cancer: pharyngeal cancer and laryngeal cancer. Pharyngeal cancer arises in the pharynx-the section of the throat located behind the nose and mouth-and can impact specific regions including the nasopharynx, oropharynx, and hypopharynx. Available treatments range from surgery and radiation therapy to chemotherapy, targeted therapy, antimetabolites, platinum-based drugs, plant-derived treatments, nitrogen mustard agents, antibiotics, and others. These therapies are administered across various end-user settings such as hospitals, multispecialty clinics, cancer research centers, and ambulatory surgical units.
The throat cancer market research report is one of a series of new reports from The Business Research Company that provides throat cancer market statistics, including the throat cancer industry's global market size, regional shares, competitors with the throat cancer market share, detailed throat cancer market segments, market trends and opportunities, and any further data you may need to thrive in the throat cancer market. This throat cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The throat cancer market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. Growth during the historical period was supported by an increase in smoking rates, a surge in alcohol consumption, a rise in HPV infections, greater prevalence of gastroesophageal reflux disease (GERD), and worsening urban air pollution levels.
The throat cancer market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Projected growth will be driven by increased demand for personalized medicine, broader adoption of tele-oncology and advanced diagnostics, greater use of genetic profiling and biomarkers, rising popularity of vaping and e-cigarettes, and an uptick in obesity and sedentary lifestyles. Key trends anticipated in the forecast period include innovations in treatment approaches, enhanced diagnostic tools using novel technologies, the emergence of new drugs and therapies, use of AI and machine learning for predictive diagnostics, and the digital integration of speech therapy solutions.
The rise in the smoking population is anticipated to drive the growth of the throat cancer market in the coming years. The smoking population refers to the proportion or number of individuals in a specific area who consistently consume tobacco products. This population is increasing due to higher stress levels, prompting more individuals to turn to smoking as a coping strategy. Throat cancer highlights the serious health risks associated with smoking, underscoring the urgent need for public awareness and preventive efforts to reduce its occurrence among smokers. For example, in October 2024, the European Respiratory Society (ERS), a Switzerland-based non-profit organization, reported a significant increase in smoking rates among young people, rising from 22.5% in 2022 to 40.1% in 2024. As a result, the growing smoking population is contributing to the expansion of the throat cancer market.
Leading companies in the throat cancer market are emphasizing the development of innovative therapies, such as immuno-oncology drugs, to improve treatment effectiveness and patient survival rates. Immuno-oncology drugs utilize the body's immune system to detect and destroy cancer cells, offering a more targeted and efficient treatment approach. For instance, in November 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, launched Toripalimab to treat nasopharyngeal carcinoma, a rare and aggressive type of throat cancer. This innovative therapy leverages immune checkpoint inhibition by targeting the PD-1 receptor, thereby enabling the immune system to better recognize and eliminate cancer cells. Toripalimab provides a new therapeutic option for patients with limited choices, potentially enhancing survival outcomes and quality of life.
In January 2024, Inovio Pharmaceuticals Inc., a US-based biotechnology company, entered into a partnership with Coherus BioSciences to advance DNA-based immunotherapies for cancer. The collaboration aims to accelerate the development of INO-3112 in combination with LOQTORZ to treat HPV-associated cancers more effectively. Through this partnership, the companies seek to improve patient outcomes by utilizing cutting-edge immunotherapy methods. Coherus BioSciences Inc. is a US-based firm specializing in the development and commercialization of immuno-oncology treatments for difficult-to-treat cancers.
Major players in the throat cancer market are Pfizer Inc., Roche Holding AG, Merck and Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories, Biocon Ltd., Coherus BioSciences Inc., Inovio Pharmaceuticals Inc., Boston Biomedical Inc., Shanghai Sunway Biotech Co. Ltd., and Odon Life Sciences.
North America was the largest region in the throat cancer market in 2024. The regions covered in throat cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the throat cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The throat cancer market consists of revenues earned by entities by providing services such as diagnostic services, immunotherapy services, palliative care services, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The throat cancer market also includes sales of chemotherapy drugs, radiation therapy equipment, immunotherapy drugs, targeted therapy drugs, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Throat Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on throat cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for throat cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The throat cancer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types: Pharyngeal Cancer; Laryngeal Cancer
2) By Treatments: Surgery; Radiation Therapy; Targeted Therapy; Chemotherapy; Antimetabolites; Platinum Derivatives; Plant Derivatives; Nitrogen Mustards; Antibiotics; Other Treatments
3) By End-User: Hospitals; Cancer Research Institutes; Multispecialty Clinics; Ambulatory Surgical Centers
Subsegments
1) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
2) By Laryngeal Cancer: Glottic Cancer; Supraglottic Cancer; Subglottic Cancer
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Throat Cancer Market Characteristics
3. Throat Cancer Market Trends And Strategies
4. Throat Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Throat Cancer Growth Analysis And Strategic Analysis Framework
5.1. Global Throat Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Throat Cancer Market Growth Rate Analysis
5.4. Global Throat Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Throat Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Throat Cancer Total Addressable Market (TAM)
6. Throat Cancer Market Segmentation
6.1. Global Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharyngeal Cancer
Laryngeal Cancer
6.2. Global Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Antimetabolites
Platinum Derivatives
Plant Derivatives
Nitrogen Mustards
Antibiotics
Other Treatments
6.3. Global Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Research Institutes
Multispecialty Clinics
Ambulatory Surgical Centers
6.4. Global Throat Cancer Market, Sub-Segmentation Of Pharyngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oropharyngeal Cancer
Nasopharyngeal Cancer
Hypopharyngeal Cancer
6.5. Global Throat Cancer Market, Sub-Segmentation Of Laryngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glottic Cancer
Supraglottic Cancer
Subglottic Cancer
7. Throat Cancer Market Regional And Country Analysis
7.1. Global Throat Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Throat Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Throat Cancer Market
8.1. Asia-Pacific Throat Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Throat Cancer Market
9.1. China Throat Cancer Market Overview
9.2. China Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Throat Cancer Market
10.1. India Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Throat Cancer Market
11.1. Japan Throat Cancer Market Overview
11.2. Japan Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Throat Cancer Market
12.1. Australia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Throat Cancer Market
13.1. Indonesia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Throat Cancer Market
14.1. South Korea Throat Cancer Market Overview
14.2. South Korea Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Throat Cancer Market
15.1. Western Europe Throat Cancer Market Overview
15.2. Western Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Throat Cancer Market
16.1. UK Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Throat Cancer Market
17.1. Germany Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Throat Cancer Market
18.1. France Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Throat Cancer Market
19.1. Italy Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Throat Cancer Market
20.1. Spain Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Throat Cancer Market
21.1. Eastern Europe Throat Cancer Market Overview
21.2. Eastern Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Throat Cancer Market
22.1. Russia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Throat Cancer Market
23.1. North America Throat Cancer Market Overview
23.2. North America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Throat Cancer Market
24.1. USA Throat Cancer Market Overview
24.2. USA Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Throat Cancer Market
25.1. Canada Throat Cancer Market Overview
25.2. Canada Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Throat Cancer Market
26.1. South America Throat Cancer Market Overview
26.2. South America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Throat Cancer Market
27.1. Brazil Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Throat Cancer Market
28.1. Middle East Throat Cancer Market Overview
28.2. Middle East Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Throat Cancer Market
29.1. Africa Throat Cancer Market Overview
29.2. Africa Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Throat Cancer Market Competitive Landscape And Company Profiles
30.1. Throat Cancer Market Competitive Landscape
30.2. Throat Cancer Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Throat Cancer Market Other Major And Innovative Companies
31.1. Bristol Myers Squibb
31.2. AstraZeneca plc
31.3. Novartis AG
31.4. GlaxoSmithKline plc
31.5. Takeda Pharmaceutical Company Limited
31.6. Eli Lilly and Company
31.7. Amgen Inc.
31.8. Astellas Pharma Inc.
31.9. Dr. Reddy's Laboratories
31.10. Biocon Ltd.
31.11. Coherus BioSciences Inc.
31.12. Inovio Pharmaceuticals Inc.
31.13. Boston Biomedical Inc.
31.14. Shanghai Sunway Biotech Co. Ltd.
31.15. Odon Life Sciences
32. Global Throat Cancer Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Throat Cancer Market
34. Recent Developments In The Throat Cancer Market
35. Throat Cancer Market High Potential Countries, Segments and Strategies
35.1 Throat Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Throat Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Throat Cancer Market In 2029 - Growth Strategies
